Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain-Reference-Cited by-同舟云学术

Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain

Published:2018-02-22 Issue:1 Volume:8 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Király Kornél,Kozsurek Márk^ORCID,Lukácsi Erika,Barta Benjamin,Alpár Alán,Balázsa Tamás,Fekete Csaba,Szabon Judit,Helyes Zsuzsanna,Bölcskei Kata,Tékus Valéria,Tóth Zsuzsanna E.,Pap Károly,Gerber Gábor,Puskár Zita

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-018-21799-8.pdf

Reference57 articles.

1. Boonacker, E. & Van Noorden, C. J. The multifunctional or moonlighting protein CD26/DPPIV. European journal of cell biology 82, 53–73, https://doi.org/10.1078/0171-9335-00302 (2003).

2. Mentlein, R. D.-peptidase IV (CD26)–role in the inactivation of regulatory peptides. Regul Pept 85, 9–24 (1999).

3. Turner, A. J., Hryszko, J., Hooper, N. M. & Dowdall, M. J. Purification and characterization of a peptidyl dipeptidase resembling angiotensin converting enzyme from the electric organ of Torpedo marmorata. Journal of neurochemistry 48, 910–916 (1987).

4. Sakurada, C., Watanabe, C., Sakurada, S., Tan-No, K. & Sakurada, T. Major metabolites of substance P degraded by spinal synaptic membranes antagonize the behavioral response to substance P in rats. Journal of pharmaceutical sciences 88, 1127–1132 (1999).

5. De Meester, I. et al. Binding of adenosine deaminase to the lymphocyte surface via CD26. European journal of immunology 24, 566–570, https://doi.org/10.1002/eji.1830240311 (1994).

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease;GeroScience;2024-04-02

2. SGLT2 and DPP4 inhibitors improve Alzheimer’s disease–like pathology and cognitive function through distinct mechanisms in a T2D–AD mouse model;Biomedicine & Pharmacotherapy;2023-12

3. Astrocytes Are a Key Target for Neurotropic Viral Infection;Cells;2023-09-19

4. Pregabalin–Tolperisone Combination to Treat Neuropathic Pain: Improved Analgesia and Reduced Side Effects in Rats;Pharmaceuticals;2023-08-07

5. Teneligliptin Co-Infusion Alleviates Morphine Tolerance by Inhibition of Spinal Microglial Cell Activation in Streptozotocin-Induced Diabetic Rats;Antioxidants;2023-07-24